Applications of carbon based electrodes for voltammetric determination of lornoxicam in pharmaceutical dosage form and human serum

Combinatorial Chemistry and High Throughput Screening

Volumn 13, Issue 7, 2010, Pages 599-609

  Bozal, Burcin ^a   Uslu, Bengi ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Boron doped diamond electrode; Glassy carbon electrode; Lornoxicam; Pharmaceutical dosage form; Serum; Voltammetry

Indexed keywords

BORON; BUFFER; CARBON; DIAMOND; LORNOXICAM; MELOXICAM; PIROXICAM; SULFURIC ACID; TENOXICAM; DRUG DERIVATIVE;

ACCURACY; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONCENTRATION (PARAMETERS); DIFFERENTIAL PULSE VOLTAMMETRY; DRUG DETERMINATION; DRUG DOSAGE FORM; ELECTRODE; HUMAN; OXIDATION; PH; POTENTIOMETRY; PRIORITY JOURNAL; REPRODUCIBILITY; SQUARE WAVE VOLTAMMETRY; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; HIGH THROUGHPUT SCREENING; METHODOLOGY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SURFACE PROPERTY;

BORON; CARBON; DIAMOND; DOSAGE FORMS; ELECTRODES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; HYDROGEN-ION CONCENTRATION; MOLECULAR STRUCTURE; PIROXICAM; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SURFACE PROPERTIES;

EID: 77955725540     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/1386207311004070599     Document Type: Article

References (35)

1. Balfour, J. A.; Fitton, A.; Barradell, L. B. Lornoxicam: A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs, 1996, 51(4), 639-657.
2. Loronoxicam. From Wikipedia the free encyclopedia. Avaialble at: http://en. wikipedia.org/wiki/Lornoxicam
3. Martindale, 34th Ed., Pharmaceutical Press, London, 2004, pp. 54.
4. Taha, E. A.; El-Zanfally, E. S.; Salama, N. N. Ratio derivative spectrophotometric method for the determination of some oxicams in presence of their alkaline degradation products. Sci. Pharm., 2003, 71(4), 303-320.
5. Nemutlu, E.; Demircan, Ş.; Kir, S. Determination of lornoxicam in pharmaceutical preparations by zero and first order derivative UV spectrophotometric methods. Pharmazie, 2005, 60(6), 421-425.
6. Taha, E. A.; Salama, N. N.; Fattah, L. E. S. A. Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz-2-oxa-1, 3-diazole (NBD-Cl). Chem. Pharm. Bull., 2006, 54(5), 653-658.
7. Patil, K. R.; Rane, V. P.; Sangshetti, J. N.; Shinde, D. B. Stabilityindicating LC method for analysis of lornoxicam in the dosage form. Chromatographia, 2009, 69 (9-10), 1001-1005.
8. Taha, E. A.; Salama, N. N.; Abdel Fattah, L. E.-S. Stabilityindicating chromatographic methods for determination of some oxicams. J. AOAC Int., 2004, 87(2), 366-373.
9. Wang, J.; Hu, X. J. Determination of lornoxicam by means of HPLC assay. Chinese Pharm. J., 2002, 37(1), 54-56.
10. Joseph-Charles, J.; Bertucat, M. Simultaneous high performance liquid chromatographic analysis of non-steroidal anti-inflammatory oxicams in pharmaceutical preparations. J. Liq. Chromatogr. R. T., 1999, 22(13), 2009-2021.
11. Radhofer-Welte, S.; Dittrich, P. Determination of the novel nonsteroidal anti-inflammatory drug lornoxicam and its main metabolite in plasma and synovial fluid. J. Chromatogr. B., 1998, 707 (1-2), 151-159.
12. Suwa, T.; Urano, H.; Shinohara, Y.; Kokatsu. J. Simultaneous high-performance liquid chromatographic determination of lornoxicam and its 5'-hydroxy metabolite in human plasma using electrochemical detection. J. Chromatogr. B., 1993, 617(1), 105-110.
13. Young, H. K.; Hye, Y. J.; Park, E.-S.; Chae, S.-W.; Hye, S. L. Liquid chromatography-electrospray ionization tandem mass spectrometric determination of lornoxicam in human plasma. Arch. Pharm. Res., 2007, 30(7), 905-910.
14. Zeng, Y. L.; Chen, X. Y.; Zhang, Y. F.; Zhong, D. F. Determination of lornoxicam in human plasma by LC/MS/MS. Acta Pharm. Sinica, 2004, 39(2), 132-135.
15. Ghoneim, M. M.; Beltagi, A. M.; Radi, A. Square-wave adsorptive stripping voltammetric determination of the anti-inflammatory drug lornoxicam. Anal. Sci., 2002, 18(2), 183-186.
16. Beltagi, A. M.; Abdallah, O. M.; Ghoneim, M. M. Determination of piroxicam in pharmaceutical formulations and human serum by square-wave stripping voltammetry. Chem. Anal.-Warsaw, 2007, 52(3), 387-398.
17. Abbaspour, A.; Mirzajani, R. Electrochemical monitoring of piroxicam in different pharmaceutical forms with multi-walled carbon nanotubes paste electrode. J. Pharm. Biomed. Anal., 2007, 44(1), 41-48.
18. Torriero, A. A. J.; Tonn, C. E.; Sereno, L.; Raba, J. Electrooxidation mechanism of non-steroidal anti-inflammatory drug piroxicam at glassy carbon electrode. J. Electroanal. Chem., 2006, 588(2), 218-225.
19. Spataru, N.; Sarada, B. V.; Tryk, D. A.; Fujishima, A. Anodic voltammetry of xanthine, theophylline, theobromine and caffeine at conductive diamond electrodes and its analytical application. Electroanalysis, 2002, 14(11), 721-728.
20. Uslu, B.; Ozkan, S. A. Solid electrodes in electroanalytical chemistry: Present applications and prospects for high throughput screening of drug compounds. Comb. Chem. High T. Scr., 2007, 10(7), 495-513.
21. Compton, R. G.; Foord, J. S.; Marken, F. Electroanalysis at diamond-like and doped diamond electrodes. Electroanalysis, 2003, 15(17), 1349-1363.
22. Fujishima, A.; Terashima, C.; Honda, K.; Sarada, B. V.; Rao, T. N. Recent progress in electroanalytical applications of diamond electrodes. New Diam. Front. C. Tec, 2002, 12(2), 73-81.
23. Iniesta, J.; Michaud, P. A.; Panizza, M.; Cerisola, G.; Aldaz, A.; Comninellis, Ch. Electrochemical oxidation of phenol at borondoped diamond electrode. Electrochim. Acta, 2001, 46(23), 3573-3578.
24. Granger, M. C.; Xu, J.; Strojek, J. W.; Swain, G. M. Polycrystalline diamond electrodes: Basic properties and applications as amperometric detectors in flow injection analysis and liquid chromatography. Anal. Chim. Acta, 1999, 397 (1-3), 145-161.
25. Ribeiro, F. W.; Cardoso, A. S.; Portela, R. R.; Lima, J. E. S.; Machado, S. A. S.; De-Lima-Neto, P.; De Souza, D.; Correia, A. N. Electroanalytical determination of promethazine hydrochloride in pharmaceutical formulations on highly boron-doped diamond electrodes using square-wave adsorptive voltammetry. Electroanalysis, 2008, 20(18), 2031-2039.
26. Zhao, X.; Hou, Y.; Liu, H.; Qiang, Z.; Qu, J. Electro-oxidation of diclofenac at boron-doped diamond: kinetics and mechanism. Electrochim. Acta, 2009, 54(17), 4172-4179.
27. Uslu, B.; Dogan-Topal, B.; Ozkan, S. A. Electroanalytical investigation and determination of pefloxacin in pharmaceuticals and serum at boron-doped diamond and glassy carbon electrodes. Talanta, 2008, 74(5), 1191-1200.
28. Altun, Y.; Dogan-Topal, B.; Uslu, B.; Ozkan, S. A. Anodic behaviour of sertindole and its voltammetric determination in pharmaceuticals and human serum using glassy carbon and borondoped diamond electrodes. Electrochim. Acta, 2009, 54(6), 1893-1903.
29. Merck Index, 13th Ed., Merck & Co., Inc., New Jersey, 2001, pp. 1000, 1040, 1346, 1632.
30. Beltagi, A. M.; Ghoneim, M. M.; Radi, A. Electrochemical reduction of meloxicam at mercury electrode and its determination in tablets. J. Pharmaceut. Biomed., 2002, 27 (1-2), 795-801.
31. Laviron, E.; Roullier, L.; Degrand, C. A multilayer model for the study of space distributed redox modified electrodes. Part II. Theory and application of linear potential sweep voltammetry for a simple reaction. J. Electroanal. Chem., 1980, 112(1), 11-23.
32. Wang, J. (Ed). Electroanalytical Techniques in Clinical Chemistry and Laboratory Medicine. VHC Publishers: New York, 1988.
33. Hart, J. P. (Ed). Electroanalysis of Biologically Important Compounds. Ellis Harward Ltd.: England, 1990.
34. nd Edition. Marcel Peker: New York, 1996.
35. ICH-Q2Bn. Validations of Analytical Procedures: Methodology, International Conferences Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Genova, Switzerland, November 1996.